Login

Progression to Insulin Therapy in Patients With Type 2 Diabetes - Dr. Peter Kokkinos, Mayo Clinic 00:00:00

Share On Facebook Share On Twitter

Progression to Insulin Therapy in Patients With Type 2 Diabetes

Recent Videos

00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences
00:10:00
James Anderson: Guanajuato Silver Expands with $50M Bolanitos Deal, Building Mexico’s Fastest-Growing Silver Producer|James Anderson,CHAIRMAN & CEO,Guanajuato Silver Company Ltd
00:10:00
Highland Copper Company Targets 2026 Construction Decision as Fully Permitted Copperwood Project Gains U.S. Federal Financing Momentum|Barry O’Shea,CEO,Highland Copper

Suggestions

00:10:00
Komatsu Ltd., led by President and CEO Tetsuji Ohashi, is a Japanese multinational corporation specializing in the manufacturing of construction, mining, and industrial equipment.
00:10:00
"Stephen Yacktman Discusses Strategies for High Valuation Markets: Insights from Yacktman Asset Management"
00:10:00
Ian Jamison on Brexit's Impact and Future M&A Trends
00:10:00
Understanding Bitcoin: Insights from a Financial Advisor - Phil Francois, CFP | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:00:00
WGBY features an overview of FuelCell Energy, highlighting its operations and significance within the energy sector | JASON FEW, PRESIDENT, CHIEF EXECUTIVE OFFICER, FUELCELL ENERGY INC
00:10:00
partner with founders building companies like Apollo|Charley Ma,Founder,Exponent
00:10:00
"Understanding the COP Climate Summit | BlackRock Basics Explains"
00:10:00
Inside the Home of Mark Zuckerberg and Priscilla Chan: A Rare Glimpse into Their Real Lives | Mark Zuckerberg ,CEO,Facebook
00:10:00
Peak Rare Earths: Advancing the Ngala Rare Earth Project in Tanzania
00:10:00
Stay Informed: Register for Crimson Tide PLC Presentations at InvestorMeetCompany | Jacqueline Daniell , CEO of Crimson Tide Plc
00:10:00
Five Key Financial Steps to Take After January 1st with Scott Sturgeon | Scott Sturgeon, Founder, Oread Wealth Partners.
00:00:00
Noxopharm details science-driven strategy in new investor presentation - Dr Gisela Mautner Chief Executive Officer and Managing Director, Noxopharm Ltd

© 2017 - Neuhu+